[No standalone website (unbranded, no questionnaire)] A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.

Find a Study Site

Study’s contact

Call center

01019313530

Email address

lobnaamer20@gmail.com

Condition

Rheumatoid Arthritis

Treatment type

Observational

Investigational product

CTHRC1 biomarker level in rheumatoid arthritis

Sponsor

Assiut University

ClinicalTrials.gov identifier

NCT04085471

Study number

Rheumatoid Arthritis

Understanding clinical trials

Get answers to your questions about clinical trials.

About the study

The purpose of the study is to determine whether plasma levels of the collagen triple helix repeat containing (CTHRC1) protein can serve as a blood-based biomarker for diagnosis of rheumatoid arthritis (RA) ,and furthermore its correlation with disease activity.

Who can take part?

You may be eligible to participate in the study if you meet the following criteria:

Inclusion criteria
  1. -Patients diagnosed as RA.
  2. Patients ( >18)who are age and sex matched with the controls
Exclusion criteria

For a full list of inclusion/exclusion criteria, please visit ClinicalTrials.gov

Study locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to apply

Determine if a study site for this clinical trial is near you. Contact the study to apply.

Find a Study Site